Patents by Inventor Mona Moller

Mona Moller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic ?-amyloid peptide
    Patent number: 6861057
    Abstract: Frameshift Mutants ?-Amyloid precursor peptides and mutant ubiquitin-B associated with Alzheimer's disease and Down syndrome eliciting T cellular immunity for use in compositions for the treatment and/or prophylaxis of Alzheimer's disease and/or Down syndrome.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: March 1, 2005
    Assignee: GemVax AS
    Inventors: Gustav Gaudernack, Jon Amund Eriksen, Mona Møller
  • Peptides
    Patent number: 6759046
    Abstract: Isolated peptides that are fragments of protein products arising from frameshift mutations in genes associated with cancer are disclosed. The isolated peptides of the invention are capable of eliciting T cell immunity against cells harboring genes with such frameshift mutations. Cancer vaccines and therapeutically effective compositions containing the peptides of the invention are also described.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: July 6, 2004
    Assignee: Gemvax AS
    Inventors: Gustav Gaudernack, Jon Amund Eriksen, Mona Møller, Marianne Klemp Gjertsen, Ingvil Sæterdal
  • Polypeptides
    Publication number: 20040072759
    Abstract: The present invention relates to polypeptides, and nucleic acids DNA encoding these polypeptides, capable of eliciting an immune reaction against cancer, methods for generating T lymphocytes capable of recognising and destroying tumour cells, and pharmaceutical compositions for the treatment, prophylaxis or diagnosis of cancer.
    Type: Application
    Filed: June 19, 2003
    Publication date: April 15, 2004
    Inventors: Gustav Gaudernack, Stein Saeboe-Larssen, Mona Moller, Jon Amund Eriksen
  • Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
    Publication number: 20030171266
    Abstract: Frameshift Mutants &bgr;-Amyloid precursor peptides and mutant ubiquitin-B associated with Alzheimer's disease and Down syndrome eliciting T cellular immunity for use in compositions for the treatment and/or prophylaxis of Alzheimer's disease and/or Down syndrome.
    Type: Application
    Filed: May 25, 2001
    Publication date: September 11, 2003
    Inventors: Gustav Gaudernack, Jon Amund Eriksen, Mona Moller